Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2014.01.13
关于召开2014年第一次暂时股东大会的通知通告
2014.01.13
关于向银行申请综合授信额度的通告
2014.01.13
拟收购SPL Acquisition Corp.股权项目资产评估报告书
2014.01.13
重大资产购置报告书(草案)
2014.01.13
第二届监事会第二十七次聚会决议通告
2014.01.13
第二届董事会第三十次聚会决议通告
2014.01.13
华英证券有限责任公司关于公司重大资产购置之自力财务照料报告
2014.01.13
SPL Acquisition Corp.及其子公司盈利展望审核报告
2014.01.13
重大资产购置报告书(草案)摘要
2013.12.27
华英证券有限责任公司关于公司重大资产购置预案之自力财务照料核查意见
第一页
上一页
113
114
115
116
117
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】